Literature DB >> 10359216

Primary socialization theory and a bio/psycho/social/spiritual practice model for substance use.

C G Leukefeld1, S Leukefeld.   

Abstract

This article supports primary socialization theory as a theory for practitioners to use in drug-user treatment and prevention interventions. Primary socialization theory is compatible with the bio/psycho/social/spiritual practice model and targeting the individual within his or her etiological domains/situation to initiate specific interventions. Governmental institutions are posited as an additional secondary socialization factor for primary socialization theory. Gender is stressed as important for primary socialization theory and is emphasized for carrying out interventions. [Translations are provided in the International Abstracts Section of this issue.]

Mesh:

Year:  1999        PMID: 10359216     DOI: 10.3109/10826089909039390

Source DB:  PubMed          Journal:  Subst Use Misuse        ISSN: 1082-6084            Impact factor:   2.164


  4 in total

1.  Longitudinal evaluations of substance abuse treatment: introduction to special issue.

Authors:  Michael L Dennis; Christy K Scott; Mark A Foss
Journal:  Eval Program Plann       Date:  2003-08-01

2.  Culturally relevant risk and protective factors for nonmedical use of prescription opioids among incarcerated African American men.

Authors:  Paris B Wheeler; Danelle Stevens-Watkins; Myles Moody; Jardin Dogan; Dominiqueca Lewis
Journal:  Addict Behav       Date:  2019-01-17       Impact factor: 3.913

3.  An experimental evaluation of recovery management checkups (RMC) for people with chronic substance use disorders.

Authors:  Michael Dennis; Christy K Scott; Rod Funk
Journal:  Eval Program Plann       Date:  2003-08

Review 4.  A computational hypothesis for allostasis: delineation of substance dependence, conventional therapies, and alternative treatments.

Authors:  Yariv Z Levy; Dino J Levy; Andrew G Barto; Jerrold S Meyer
Journal:  Front Psychiatry       Date:  2013-12-19       Impact factor: 4.157

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.